NLRP3 and depressive symptom measurement: Notably, our observations suggest a significant influence of VTX on this specific molecular pathway, aligning with other studies that show certain antidepressants affecting NLRP3 and ASC expression across the hippocampus to improve depression-like behaviors [70].